PainChek Ltd at NWR Healthcare Conference (Virtual) Transcript
Hello and welcome back to the NWR Virtual Healthcare Conference. My name is Matt Wright. Next up, we have PainChek which is listed on the ASX under the ticker, PCK. And joining us from PainChek is the CEO, Philip Daffas. Prior to PainChek, Philip's previous roles included VP of global marketing at Cochlear and global marketing with Roche Diagnostics based in the German headquarters of that company.
Before we get started, and a reminder to everyone, if you have a question, please feel free to submit it using the Q&A panel within Zoom, and we'll get to those at the end. But I'll pass it over to Philip to go through the slides first. So please go ahead.
Thank you, Matt. And welcome to everyone, and thanks for joining us this afternoon. I'll be presenting the PainChek results in the December quarter and the overall good business progress of the company.
As we see today, PainChek is progressing very positively on all fronts of position for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
